Printer Friendly

Articles from The Fly (December 17, 2018)

1-158 out of 158 article(s)
Title Author Type Words
ABB confirms plans to sell Power Grids unit to Hitachi. 316
Achillion reports positive interim data for ACH-4471 Phase 2 trials. 195
Aclaris Therapeutics provides update on three clinical trials for ATI-502. 349
Air Products announces NA price increase for liquid and bulk industrial gases. 110
Alkermes, Biogen announce diroximel fumarate NDA submitted to FDA. 111
Alkermes; Biogen: Alkermes submits NDA to FDA for diroximel fumarate. 107
Alliance Resource Partners to acquire oil, gas mineral interests for $175.96M. 326
Allstate enters $1B share buyback pact with Wells Fargo. 227
Amazon offloads costs, risks to delivery startups to meet demand, Bloomberg says. 112
Amazon rethinks unprofitable items amid focus on the bottom line, WSJ reports. 112
American Electric Tech enters into share exchange agreement with Stabilis. 127
Ameris Bancorp, Fidelity Southern to merge in all-stock transaction. 358
Apple device assemblers not in settlement talks with Qualcomm, Reuters reports. 128
Athersys announces extension of HEALIOS K.K.'s exclusive period. 109
Avis Budget to connect additional 75,000 cars though I.D. Systems devices. 128
BAE Systems receives $96.6M U.S. Army contract modification. 105
Barrick announces Jersey Court approval of merger with Randgold. 133
Barrick Gold raises quarterly dividend to 4c from 3c per share. 102
BASF to continue price increases to offset higher raw material costs, WSJ says. 107
Baytex Energy announces 2019 capital budget of $550M-$650M. 135
Bearish option flow in Banco Bradesco. 101
Boeing jumps in after-hours trading after repurchase, dividend raise. 101
Boeing to acquire 80% of new joint venture with Embraer for $4.2B. 323
BofA/Merrill downgrades Best Buy to Underperform on industry slowdown concerns. 101
Bristol-Myers announces positive CHMP opinion recommending Sprycel. 115
Bristol-Myers, Boston Medical Center announce I-O research collaboration. 148
Bristol-Myers, H3 Biomedicine announce new research collaboration agreement. 154
California regulator says PG&E falsified gas safety records, WSJ reports. 161
Call spreads in ProPetro Holding Corp as a bullish position is adjusted. 107
Canada manufacturing preview. 123
Canadian Solar, TrailStone sign 10-year PPA for solar portfolio in Italy. 183
CBS board determines there are grounds to terminate Moonves for cause. 303
Centene selloff on ACA ruling brings attractive entry point, says Piper Jaffray. 127
Centene: 2019 peak enrollment to exceed 2018 by 150,000-200,000 members. 129
Concert Pharmaceuticals initiates Phase 1 clinical program of CTP-692. 272
Corbus Pharmaceuticals initiates Phase 3 DETERMINE trial. 111
CrossAmerica, Couche-Tard to exchange $184.5M in assets. 265
Cruiser Caiptal criticizes Ashland for rejecting its board nominees. 219
Darling Ingredients opens new organic fertilizer plant in Turlock, CA. 142
David Gao 'disappointed' over dismissal of lawsuit against China Biologic. 332
Defensive option play in Invesco QQQ Trust as shares drop 1.1%. 109
Diffusion Pharmaceuticals awarded patent for use of TSC in conjuction with tPA. 287
DOOM puts see action in Transocean as shares near 18month lows. 126
Doubleline's Gundlach said this "seems to be a bear market". 174
DropCar to sell Suisun operations for $3.5M. 138
Eli Lilly announces Taltz meets primary, secondary endpoints in SPIRIT-H2H study. Clinical report 230
Emergent BioSolutions receives Health Canada approval for anthrax vaccine NDS. 166
Emerson selloff on drop in oil price overdone, says JPMorgan. 120
Enbridge Energy,Enbridge Energy Management announce approval of proposed mergers. 205
Endeavour Silver to cut production rate at El Cubo mine by about 50% in 2019. 149
Evofem AMPOWER Phase 3 trial meets primary endpoint. Medical condition overview 232
Fed funds futures are fractionally higher. 152
Fed should pause both its rate hikes and balance sheet wind down. 159
FibroGen says roxadustat approved in China for treatment of anemia. 109
Fin Cen announces $14.5M assessment against UBS for vioations against BSA. 168
FleetCor enters into $220M Accelerated Share Repurchase program. 208
Flexion submits supplemental NDA for ZILRETTA. 310
Fly Intel: After Hours Movers. 186
Fly Intel: Pre-market Movers. 266
Fly Intel: Top five analyst downgrades. 171
Fly Intel: Top five analyst upgrades. 189
FOMC Checklist:. 104
FOMC Forecast revisions. 191
Four Corners Property Trust acquires six Red Lobster properties for $25.9M. 145
FX Update: Narrow ranges have prevailed. 153
FX Update: The dollar has been under moderate pressure. 207
Globalstar jumps over 23% after litigation setttlement and 3GPP approval. 212
Golar LNG receives limited notice to proceed for FLNG vessel. 122
Goldman starts Argenx at Conviction Buy, upgrades Orchard to Buy. 166
Google ended China search engine after internal complaints, Intercept says. 123
Google to spend $1B to establish new campus in New York. 190
Gundlach sees the next major risk as the dollar. 121
Hancock Jaffe Laboratories receives INVIMA approval for VenoValve trial. 187
Incyte, Innovent announce strategic collaboration, licensing agreement. 263
Insys Therapeutics provides update to strategic review process. 177
Intel to be rewarded long-term for continued transformation, says MKM Partners. 104
IRET announces 1-for-10 reverse stock split. 164
J&J stock reaction, comparisons to Bayer 'flawed,' says Morgan Stanley. 155
Jack in the Box exploring strategic, financing alternatives. 187
Johnson & Johnson announces $5B share repurchase program. 105
KCAP Financial announces 67c per share transaction agreement with BC Partners. 181
Keysight Technologies, MediaTek collaborate for 5G multimode devices. 134
Kinder Morgan approves $49M investment in Plantation Pipe Line System. 167
Kineta unit enters license agreement with Pfizer to develop cancer treatment. 158
KKR puts lead calls 14:1 and implied volatility is at 52-week highs. 120
Ligand acquires milestone, royalty rights to PTX-022 from Palvella. 237
Lincoln Financial Group announces eMoney, Redtail integrations. 179
Loop sees Albemarle 'narrative shift' as positive for Livent thesis. 167
Lululemon upgraded to Buy from Hold at Stifel. 133
Lumentum price target raised to $65 from $60 at Craig-Hallum. 101
Medtronic announces FDA approval of InterStim smart programmer. 110
Merck: EC approves KEYTRUDA for treatment of stage III melanoma. 167
MLB could switch to streaming after Disney-21st Century Fox deal, NY Post says. 110
Molina Healthcare comments on recent ACA ruling. 101
Mylan announces U.S. launch of generic Canasa suppository. 122
Needham calls Arista single best idea in Networking for 2019. 103
Needham names Ionis a top 2019 pick, boosts target to $82. 101
Netflix taps former ABC entertainment head as VP of original content, WSJ says. 119
Neurotrope announces $22.5M registered direct offering. 167
Neurotrope announces publication of data from Phase 2 study of Bryostatin-1. 353
Nissan forms special committee on governance, continues talks on chairman role. 336
Northrop Grumman awarded $3.6B Air Force contract for LAIRCM equipment, support. 107
Novavax calls lead puts 40:1 after a strong week. 134
Nu Skin adopts restructuring program, sees pre-tax charges of about $70M in Q4. 180
Nxt-ID says proposed spin-off of payments division delayed. 198
Oracle CEO Catz says 'confident' in continuing strong EPS growth in 2H. 194
Oracle rises after better-than-expected Q2 results. Financial report 245
OSI Systems receives IDIQ contract valued up to $450M. 101, tZERO to develop commodity contract token for GSR Capital. 149
Ovid shares should be up more on epilepsy data, says Piper Jaffray. 105
Ovid Therapeutics: Phase 1b/2a trial of OV935/TAK-935 met primary endpoint. 123
Piper says Sophiris data 'as expected,' remains buyer of shares. 110
PlayAGS to acquire Integrity Gaming for $49M in cash. 132
Pluristem provides recap of KOL meeting on PAD. 231
Possible drone crash into Aeromexico plane renews focus on safety, WSJ reports. 143
ProQR Therapeutics announces publication of QR-110 data in Nature Medicine. 290
Proteostasis announces global license agreement with Genentech. 133
Puma Biotechnology reports top-line results from Phase III NALA trial. 365
Put buyers in Chicos FAS as shares gain 3.3%. 101
Roche SMA treatment risdiplam granted PRIME designation by EMA. 136
Roku initiated with a Hold at SunTrust. 105
Scientific Games announces three executive promotions. 158
SEC says BNY Mellon to pay over $54M for improper handling of ADRs. 262
Shire announces FDA approval of Motegrity for treatment of CIC. 371
Sol-Gel Technologies initiates Phase 3 TWIN clinical program. 183
Sophiris Bio provides update on Phase 2b localized prostate cancer trial. 131
Spartan Motors adopts 10b5-1 trading plan for share repurchases. 109
SPI Energy receives delinquency notice from Nasdaq. 157
Tegna says John Janedis is joining the company as SVP capital markets, IR. 176
Teva announces FOCUS study met primary, secondary endpoints. 296
TG Therapeutics announces publication of Phase 1/1b umbralisib results. 272
The Empire State headline fell sharply. 264
Three-way put spread in SPDR Biotech Fund as a bearish position is adjusted. 135
Tilray signs LOI to purchase hemp-derived CBD from LiveWell Canada. 150
TransCanada to sell Coolidge Generating Station for $465M. 148
Treasury Action: yields tumbled lower heading. 123
Treasury capital flows (TIC) preview: the October data will be scrutinized. 144
Treasury Market Outlook: Treasury yields have dipped 1 bp lower. 174
Treasury TIC report: foreigners bought $42.0 B in net U.S. assets in October. 200
Treasury's $75 B 3- and 6-month bill auctions were well received. 148
Trinity Industries CFO James Perry to depart. 159
Twitter discloses issue related to support forms. 290
U.S. Empire State index dropped 12.4 points in December to 10.9. 157
U.S. equities continue to backtrack. 177
U.S. equities have rolled back over again. 184
U.S. ethan producers want pricing changes as markets fall, Reuters says. 149
U.S. VIX equity volatility is up 4.5% near 22.60. 125
UroGen Pharma initiates rolling submission of NDA for UGN-101. 142
Verint to acquire ForeSee. 141
Village Super Market appoints co-presidents, Robert Sumas will remain CEO. 107
W.R. Grace will continue program to raise FCC catalyst prices by 3%-9% in 2019. 116
Walt Mossberg says he's quitting Facebook, Instagram, Messenger. 159
Weatherford announces $50M sale of surface data logging business. 219
WWE, Sky extend partnership in New Zealand. 153
Wynn Resorts says Maurice Wooden stepping down as Wynn Las Vegas president. 142
XPO shares offer 'significant long-term upside,' says Barclays. 112
Zayo to expand East Coast data center presence. 114
Zynerba provides update on clinical progress. 167

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters